Digong forgot to mention the cure for Covid-19 The Manila Times – The Manila Times

ONE of the highlights in President Rodrigo Digong Dutertes fifth State of the Nation Address (SONA) was his proposal to Congress to revive the death penalty through lethal injection.

The death penalty law was passed during the term of President Fidel Ramos, but was scrapped by President Gloria Macapagal Arroyo, who gave in to pressure from the Catholic Church.

The death penalty could decrease the commission of heinous crimes.

Digong said drug offenses would be covered by his proposed death penalty.

But how about rape with homicide, rape of a minor, murder, robbery with homicide and large-scale estafa?

How about law enforcers who commit grave offenses using their badges as a shield? Among the serious crimes by law enforcers is planting evidence on innocent citizens.

How about government officials who coddle big-time criminals?

The above-cited offenses should have been included by Digong as punishable by lethal injection.

If Congress considers the Presidents proposal to restore the death penalty, it should include the other heinous crimes mentioned above.

* * *

Congress should not listen to bleeding hearts like Amnesty International since they refuse to see the real crime situation in the Philippines.

Bleeding hearts were not able to stop the death penalty in many countries, including some states in the United States.

Why should they stop our country from restoring the death penalty?

* * *

I was expecting the President to announce the discovery by Filipino doctors of a cure for seriously ill coronavirus disease 2019 (Covid-19) patients in the SONA.

The citizenry, cowering in fear of the dreaded illness, would have appreciated the Presidents speech more if he had included the medical breakthrough.

The medical breakthrough was announced by Palace spokesman Harry Roque Jr. in a virtual press conference in Malacaang several days before the SONA.

However, the story was buried in the inside pages of major newspapers, a treatment it did not deserve.

The discovery of the cure for Covid-19 was made by scientists at The Medical City hospital through its Institute of Molecular Medicine stem cell program.

Stem cells taken from the blood of preserved umbilical cords worked their magic on six patients about to be intubated through intravenous injections.

I wrote about the medical breakthrough in my column last Tuesday, July 28.

For those who missed that column, you may want to read it at the Manilatimes.net.

* * *

A big supply of umbilical cords would bring down the cost of the stem cell therapy for Covid-19.

Tens of thousands of women give birth in the country and the umbilical cords of the newborns are thrown away.

The possible sources of umbilical cords are government hospitals and paanakan (maternity) centers.

The Philippines is a big manufacturer of babies.

Proof is that for a small country, our population has ballooned to 110 million.

To digress, I was a medical representative (detailman) in 1973 and one of the hospitals in Metro Manila that I was assigned to cover was the Fabella Memorial Hospital, a maternity hospital, in Sta. Cruz, Manila.

As I was fixing the promotional medicines I would give to some doctors at Fabella, I heard the screams of pain by a woman about to give birth at the delivery room.

Armando, Armando! P****g i*a mo! the woman was shouting, apparently referring to her husband.

I heard the nurse or midwife tell the woman, Tumigil ka nga diyan! Huwag mong sisihin ang asawa mo. Taun-taon nandito ka (Shut up! Dont blame your husband. Youre here every year).

See what I mean by the country being a manufacturing center of babies?

* * *

Another highlight of the Presidents SONA was his plan to establish the Coconut Farmers Trust Fund.

That part of Digongs speech was near to my heart as I come from Davao Oriental, a province where the main livelihood of the people is harvesting coconuts and turning them into copra.

Coconut farmers are the poorest in the country.

It was not so before, say, in the 1960s, when the price of copra was very high and coconut farmers in my hometown Manay could send their children to very good schools in Davao City and elsewhere.

But the price of copra in the world market is now very low and Filipino coconut farmers have become impoverished as a result.

However, the dying coconut industry might soon come to life again and the farmers could be rich once more.

An American friend of mine, Matt Grecsec, has invented a machine that converts coconut husk into hardwood for construction materials.

Grecsec, whos from Florida and married to a Filipina, has been coming to the Philippines looking for a place to set up his plant to make hardwood out of coconut husk.

Coconut husk is thrown away by farmers who make copra.

Grecsec has been meeting with Agriculture Secretary William Dar who has expressed enthusiasm for his project.

The rest is here:
Digong forgot to mention the cure for Covid-19 The Manila Times - The Manila Times

$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region – Forecast to 2025 – ResearchAndMarkets.com – Yahoo Finance

The "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global cell expansion market is projected to reach USD 30.06 billion by 2025 from an estimated USD 14.91 billion in 2020, at a CAGR of 15.1%.

The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users). The report also provides a comprehensive review of market drivers, restraints, and opportunities in the cell expansion market.

Increasing incidence of chronic diseases and government investments for cell-based research are set to drive the cell expansion market

Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.

By instruments type, the cell expansion supporting equipment accounted for the fasted growing product segment of the cell expansion market

The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. The cell expansion supporting equipment market includes flow cytometers, cell counters and hemocytometers, centrifuges, and other supporting equipment. They are used in cell culture processes for isolating, culturing, scaling-up, and extracting biological products. These instruments are essential in laboratories and institutes for conducting research and analyzing the cell structure and function for cell therapy research.

By cell type, the human cells segment accounted for the largest share of the cell expansion market

Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. The human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

Asia Pacific: The fastest-growing region in the cell expansion market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the increasing focus of players on emerging Asian markets, increasing incidence of chronic and infectious diseases, rising geriatric population, and government initiatives for infrastructural improvements of healthcare facilities are driving the growth of the cell expansion market in this region.

North America: the largest share of the cell expansion market

North America accounted for the largest share of the cell expansion market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.

Company Profiles

Established Companies

Start-up Companies

For more information about this report visit https://www.researchandmarkets.com/r/y35ufs

View source version on businesswire.com: https://www.businesswire.com/news/home/20200729005450/en/

Contacts

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Follow this link:
$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com - Yahoo Finance

Dreambody.clinic – Stem Cells, HGH, TRT, Hormone …

Mesenchymal Stem Cell Therapy

At Dream Body Clinic we offer Mesenchymal Stem Cell Therapy Treatments for Autoimmune disorders, Chronic Degenerative disorders, Articulations, Cosmetic Issues and more.

Our Mesenchymal Stem Cells are derived from Umbilical cord (Wharton Jelly) and Placenta. All donors are under 30 years old and put through a stringent screening process to ensure we only have gold quality stem cells. This tissue that we derive from is the youngest possible source for stem cells. This means that the stem cells we administer are as young and healthy as possible. There is no chance of rejection as mesenchymal stem cells lack human leukocyte antigen (HLA). HLA is what the immune system looks for to detect intruders. Our stem cells are sourced in the best way possible and then cultivated to provide the tens of millions or hundreds of millions of stem cells needed for a successful stem cell therapy.

Our Mesenchymal Stem Therapy Treatments have many anti-aging benefits. We are able to effect the whole body with a stem cells anti-aging IV Treatment or focus on specific areas like the face or hair. The stem cells target inflammation and then fix the route cause. Chronic inflammation always speeds up aging so this is the first way anti-aging stem cells effect. Next they donate mitochondria to weak cells. The mitochondria are like the engines of the cells and by having fresh, new mitochondria they have more energy and work better. The stem cells have also been found to extend telomere length in at least 6 types of cells. It is believed that research will show they do this for even more cells. The stem cell facial treatment is able to restore collagen and fat below the surface of the skin. This fills in the lines and restores a youthful appearance. It also improves skin quality and thickness. The Stem Cell Hair Restoration Treatment allows hair follicles that are closing to re-open. They also help regenerate the existing hair. stem cell therapy for anti-aging is wonderful

Our Diabetes Stem Cell Treatment is extremely effective at mitigating the negative effects of Type 2 diabetes. The mesenchymal stem cell treatment for Type 2 diabetes is an IV of 300 Million mesenchymal stem cells. These stem cells send out cytokines that effectively reprogram the immune system to protect the pancreas instead of attacking it. This leads to stabilized blood glucose levels and proper insulin response. A proper diet with low sugar and low fast carbohydrates is needed to maintain results, but the stem cell treatment has a profound effect on Type 2 diabetes. Learn more about our Type 2 Diabetes Stem Cell Therapy.

Our Lyme Disease Stem Cell Treatment is extremely effective at mitigating the negative effects of Lyme disease. The mesenchymal stem cell treatment for Lyme disease is an IV of 300 Million mesenchymal stem cells. These stem cells send out cytokines that effectively reprogram the immune system to protect the body instead of attacking it. This leads to feeling normal again. Learn more about our Lyme Disease Stem Cell Treatment.

Our HGH Legal Fly & Buy Program is our longest running program that we have been doing for 8 years. It is legal to seek medical treatment abroad and return home with any prescribed medication. We start with a blood panel to make sure you are healthy and then prescribe the HGH to meet your country of origins law. For the USA that is 50 dose units and the rest of the world is a 90 day supply. We can legally send you home with up to 720 IU of pharmaceutical HGH like Norditropin HGH, Genotropin HGH or Humatrope HGH. That is enough for 2IU a day for a year. Learn more about our HGH Legal Fly & Buy Program.

Our Genotropin HGH Legal Fly & Buy Program is the best. We can legally send you home with up to 720 IU of Genotropin HGH. Enough for 2IU a day for a year. Buy HGH the legal way. Learn more about our Genotropin HGH Legal Fly & Buy Program.

Our Norditropin HGH Legal Fly & Buy Program is the best. We can legally send you home with up to 720 IU of Genotropin HGH. Enough for 2IU a day for a year. You can now buy HGH Legally! Learn more about our Norditropin HGH Legal Fly & Buy Program.

Our Humatrope HGH Legal Fly & Buy Program is the best. We can legally send you home with up to 720 IU of Humatrope HGH. Enough for 2IU a day for a year. You can finally buy HGH Legally! Learn more about our Humatrope HGH Legal Fly & Buy Program.

Our Testosterone Replacement Therapy TRT Legal Fly & Buy Program is the best. We can legally send you home with up to 100ml of Testosterone. That is enough to last 2 years at 1ml a week. You can finally buy TRT at the dose you want Legally! Learn more about our Testosterone Replacement Therapy TRT Legal Fly & Buy Program.

Our Proviron Legal Fly & Buy Program is the best. We can legally send you home with up to 80 boxes of proviron. You can finally buy Proviron at the dose you want Legally! Learn more about our Proviron Legal Fly & Buy Program.

Our Deca Durabolin Legal Fly & Buy Program is the best. We can legally send you home with up to 50 boxes of Deca Durabolin. You can finally buy Deca Durabolin at the dose you want Legally! Learn more about our Deca Durabolin Legal Fly & Buy Program.

Our Anavar (Oxandralone) Legal Fly & Buy Program is the best. We can legally send you home with up to 6 bottles of Anavar (Oxandralone). You can finally buy Anavar (Oxandralone) at the dose you want Legally! Learn more about our Anavar (Oxandralone) Legal Fly & Buy Program.

Our Modafinil Legal Fly & Buy Program is the best. We can legally send you home with up to 8 boxes of Modafinil. You can finally buy modafinil at the dose you want Legally! Learn more about our Modafinil Legal Fly & Buy Program.

See more here:
Dreambody.clinic - Stem Cells, HGH, TRT, Hormone ...

Family need to raise 120K by September for lifesaving treatment for 11-year-old – Cheshire Live

The family of a brave 11-year-old Wistaston boy needs to raise 120,000 by September so he can have lifesaving treatment in Asia to stop a rare form of bone cancer returning.

Georgy Capener was diagnosed with the highly malignant Ewings Sarcoma after a fall in a friends back garden on Easter Sunday in 2018.

Since then the plucky Wistaston Church Lane pupil has undergone numerous rounds of high dose aggressive chemotherapy and radiotherapy.

As a result of the treatment he lost his right arm which has been replaced a titanium prosthesis.

Georgy went into remission in March of last year and life returned to a semblance of normality for the Crewe boy, his mum Helen, dad Richard, and sisters Ellie, 18, and Chloe, 13.

But in April this year the family were dealt another devastating blow when they learned the cancer had returned - this time in Georgys left sinus, just under his eye socket and in the back of his nose.

Helen told CheshireLive: Everything had been going really well and then there was the impact of the coronavirus pandemic so one scan [to check Georgy] was moved further on but we never got to it because he started having really painful headaches. I knew something wasnt right.

Georgys parents were told that, because of the location of the tumour, there was a chance he could lose his eyesight or suffer a stroke during the biopsy he needed.

Helen told how, at first, she didnt want him to have the biopsy, but she knew he had to.

We didnt know if he was going to come out with his eyesight or have a stroke but he came through it, she said. Hes so brave, hes been so brave throughout.

Georgy, who is a passionate Liverpool fan, is now undergoing chemotherapy and radiotherapy again.

The tumour cannot be removed surgically because of its location.

But the vital stem cell therapy which is essential to ensure he can live a normal, healthy life and prevent the cancer returning at a later stage costs 130,000 and is not available for Georgy on the NHS.

Helen said: After lengthy discussions with a stem cell transplant hospital in a top medical treatment centre in Thailand, we are thrilled that they are willing to accept Georgy.

The transplant will involve removing the faulty mother cell and harvesting new purified cells from a donated umbilical cord into his body to stop the cancer from returning. These procedures have very high success rates.

Georgy is due to finish his sixth and final round of chemotherapy at the beginning of September.

For the stem cell treatment to be successful the procedure would have to start immediately after that to ensure the cancer doesnt return straight away.

The family has set up a JustGiving appeal to raise the funds needed to save their little boys life. They need to raise 120,000 by the beginning of September.

Helen said: We set it up in the hope that we can raise some of this amount to help save our sons life. It is our only realistic option and, for the first time in a long time, we can be positive and see some sort of future.

If you can help please donate by visiting JustGiving here.

See the original post:
Family need to raise 120K by September for lifesaving treatment for 11-year-old - Cheshire Live

Global trade impact of the Coronavirus Synthetic Stem Cells Market Report 2020-2026 Research Insights 2020 Global Industry Outlook Shared in Detailed…

Synthetic Stem Cells Market report covers the Introduction, Product Type and Application, Market Overview, Market Analysis by Countries, Market Opportunities, Market Risk and Market Driving Force. Under Coronavirus (COVID19) outbreak globally, this Synthetic Stem Cells industry report provides 360 degrees of analysis from Supply Chain, Import and Export control to regional government policy and future influence on the industry.Focuses on the topmost key Synthetic Stem Cells market manufactures/players like(North Carolina State University, Zhengzhou University), to define, describe and analyze the Sales Volume, Value, Market Share, Capacity, Production, Price, Revenue, Cost, Gross, Gross Margin, Synthetic Stem Cells Market Competition Landscape, SWOT Analysis and Development Plans in next few years.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Synthetic Stem Cells[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2395700

Which Prime Data Figures are Included in This Synthetic Stem Cells Market Report-Market size (Last few years, current and expected); Market share analysis as per different companies; Synthetic Stem Cells Market forecast; Demand; Price Analysis; Synthetic Stem Cells Market Contributions (Size, Share as per regional boundaries).

Scope of Synthetic Stem Cells Market:Synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Cancers Wounds and Injuries Musculoskeletal Disorders Blood disorders

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Cardiovascular Diseases Neurological Disorders Other Diseases

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2395700

Synthetic Stem Cells Market Regional Analysis Covers:

Some Important Highlights From The Synthetic Stem Cells Market Report Include:

To Get Discount of Synthetic Stem Cells Market:https://www.researchmoz.us/enquiry.php?type=D&repid=2395700

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Go here to see the original:
Global trade impact of the Coronavirus Synthetic Stem Cells Market Report 2020-2026 Research Insights 2020 Global Industry Outlook Shared in Detailed...

Orthopedic Regenerative Medicine Market Insights and Business Outlook By Top Players Curasan, Inc., Carmell Therapeutics Corporation, Anika…

A new business intelligence report released by CMI with title GlobalOrthopedic Regenerative Medicine MarketResearch Report 2019-2027 is designed covering micro level of analysis by manufacturers and key business segments. The Global Orthopedic Regenerative Medicine Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Curasan, Inc., Carmell Therapeutics Corporation, Anika Therapeutics, Inc., Conatus Pharmaceuticals Inc., Histogen Inc., Royal Biologics, Ortho Regenerative Technologies, Inc., Swiss Biomed Orthopaedics AG, Osiris Therapeutics, Inc., and Octane Medical Inc.

Whats keeping Curasan, Inc., Carmell Therapeutics Corporation, Anika Therapeutics, Inc., Conatus Pharmaceuticals Inc., Histogen Inc., Royal Biologics, Ortho Regenerative Technologies, Inc., Swiss Biomed Orthopaedics AG, Osiris Therapeutics, Inc., and Octane Medical Inc. Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

Leading players of Orthopedic Regenerative Medicine Market:

Curasan, Inc., Carmell Therapeutics Corporation, Anika Therapeutics, Inc., Conatus Pharmaceuticals Inc., Histogen Inc., Royal Biologics, Ortho Regenerative Technologies, Inc., Swiss Biomed Orthopaedics AG, Osiris Therapeutics, Inc., and Octane Medical Inc.

Orthopedic Regenerative Medicine Geographical Segmentation Includes:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of L.A.)

Middle East and Africa (Turkey, GCC)

The research report includes an exploration of the competitive landscape present in the Orthopedic Regenerative Medicine Market. It includes an import of the current and future trends that players can invest in. Likewise, it also includes an estimation of the business outlooks of the players and explains the nature of the competition.

Orthopedic Regenerative Medicine Market Segmentation

By Procedure Cell TherapyTissue EngineeringBy Cell TypeInduced Pluripotent Stem Cells (iPSCs)Adult Stem CellsTissue Specific Progenitor Stem Cells (TSPSCs),Mesenchymal Stem Cells (MSCs)Umbilical Cord Stem Cells (UCSCs)Bone Marrow Stem Cells (BMSCs)By SourceBone MarrowUmbilical Cord BloodAdipose TissueAllograftsAmniotic FluidBy ApplicationsTendons RepairCartilage RepairBone RepairLigament RepairSpine RepairOthers

The plus point of this research study is that it includes the impact of COVID-19 to the Orthopedic Regenerative Medicine market. The data summarized within this research study includes forecast from 2020 to 2027. COVID-19 has significantly impacted each and every market on the global platform. If you have any specific requirement then Please get in touch with us. Our Expert team will provide as per report customized to your requirement.

Important Features of the report:

Reasons for buying this report:

It offers the regional analysis of the Orthopedic Regenerative Medicine Market along with the business profiles of several stakeholders.

Some Major TOC Points:

Chapter 1. Orthopedic Regenerative Medicine Market Report Overview

Chapter 2. Orthopedic Regenerative Medicine industry Growing Trends

Chapter 3. Market Share by Key vendors

Chapter 4. Orthopedic Regenerative Medicine Market Breakdown Data by Type and Application

Chapter 5. Orthopedic Regenerative Medicine Market by End Users/Application

Chapter 6. COVID-19 Outbreak: Orthopedic Regenerative Medicine Industry Impact

Chapter 7. Opportunity Analysis in Covid-19 Crisis

Chapter 9. Market Driving Factors

And Many More

Apply Promo Code CMIFIRST1000 And Get Instant Discount OfUSD 1000

Download PDF Brochure Of this Report @https://www.coherentmarketinsights.com/insight/request-pdf/3566

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US

Mr. Shah US +1-206-701-6702/UK +44-020 8133 4027 Email: [emailprotected]arketinsights.com

More here:
Orthopedic Regenerative Medicine Market Insights and Business Outlook By Top Players Curasan, Inc., Carmell Therapeutics Corporation, Anika...

Books: Five new books to read this week – HeraldScotland

All The Lonely People by Mike Gayle is published in hardback by Hodder & Stoughton, priced 14.99 (ebook 4.99)

Hubert Bird is old and lonely. In weekly phone calls to his daughter Rose, who lives in Australia, he paints the picture of a perfect busy retirement, filled with friends and outings, when the reality is anything but. When Rose announces she is coming to stay, he realises he needs to make some changes. A young mother moves into the neighbourhood and the pair strike up an unlikely friendship as they start a campaign to tackle loneliness in the area. This timely and poignant book flits between present day and Hubert's early life, emigrating to the UK as one of the Windrush generation. Mike Gayle's writing is beautiful and engaging and All The Lonely People is both heartbreaking and uplifting, devastating and thought-provoking. It is the kind of book you will want to press into the hands of everyone you know and tell them to read immediately.

All Adults Here by Emma Straub is published in hardback by Michael Joseph, priced 14.99 (ebook 9.49)

The challenging journey through adulthood is explored with perceptive wit in Emma Straub's entertaining new novel. All Adults Here charts the complicated relationships of the Strick family in the fictional small US town of Clapham. At its heart is family matriarch Astrid, who witnesses a shocking tragedy that sparks a re-examination of her life. As she opens up to her adult children - frustrated Elliott, single-mum-to-be Porter and bohemian Nicky - it turns out they also have secrets and hang-ups to spill. Straub endearingly portrays her central characters as they tangle with a multi-generational crew of friends and relatives. Her easy writing style combines wry humour with the occasional poignant insight. At times the comic tone feels jarring when the novel addresses more serious themes, skipping too lightly over a character's inner complexities. But this is a book that whips along with feel-good momentum, driven by warmth and love.

Pondweed by Lisa Blower is published in hardback by Myriad Editions, priced 12.99 (ebook 5.58)

Lisa Blower is a highly-regarded short-story writer, and her new novel tells the story of an unlikely road trip undertaken by two endearing and idiosyncratic people. Pondweed centres on a couple of late 60-somethings, Selwyn and Ginny. Next-door neighbours in their youth, they once courted and have now got together again - after a fashion-following a 50-year interval. They think they know each others' distant pasts intimately - but are not so strong on anything since. In the interim, Ginny had a daughter and not much else happened for her; Selwyn developed his passion for ponds. But cheated by his business partner out of his pension, Selwyn decides to take the pair of them off on a trip down memory lane in the direction of Wales, armed only with a stolen caravan full of booze and ornamental fish. The road trip quickly turns out to be a painful, poignant and charming journey through the couple's past, as a series of apparently impromptu stop-offs start to trigger forgotten memories, unresolved conflicts, and only partially buried secrets. An unlikely romance between two people who are meant for each other, but don't know how to be together, Pondweed is a delightful read.

Sex Robots & Vegan Meat by Jenny Kleeman is published in hardback by Picador, priced 12.99 (ebook 8.99)

Synthetic wombs, do-it-yourself euthanasia, AI sex robots and meat grown from stem cells: are these the plots of dystopian horror movies or the technologies that will save the future of humankind? Documentary film-maker and journalist Jenny Kleeman explores birth, death, sex and food, navigating opinions, facts and half-truths. In doing so, she must negotiate with an array of distinctive characters (including evangelistic vegans, competitive scientists, and even incels), all of whom vie for centre stage. The real treat is Kleeman's insatiable curiosity, pushing her to ask the difficult questions, even when conversations take an awkward turn (as they so often do). Coupled with her own knee-jerk emotions, assumptions and personal views, her narration ends up being part fact-finding mission, part-storytelling. Whether she's right or wrong isn't really the point; it's whether you agree, disagree, or are downright horrified by the promises of this whole new world. A moreish page-turner of a book that will leave you feeling informed and ready for the next dinner party.

Children's book of the week

The Secret Explorers and the Comet Collision is published in hardback by DK, priced 15.31 (ebook 2.99)

Space and the universe are the setting for the first instalment of DK's new educational series for children, which introduces us to the Secret Explorers, a team of elite mini adventurers. Each of the eight explorers has a unique expertise and has been brought together from around the world to solve special secret missions. In Comet Collision - one of two initial books in the series - space whiz Roshni and rain forest expert Ollie are picked to blast off for a mission to Jupiter to fix a broken space probe. We see Roshni go on a daring spacewalk as the duo work against the clock to complete their mission before a comet strikes. From facts about Jupiter's rings and space probes to asteroids and gravity, the story is perfect for little stargazers aged seven and above, though it can be a little clunky at times during the educational bits.

See the original post:
Books: Five new books to read this week - HeraldScotland

American Academy of Stem Cell Physicians is Hosting an FDA Safety Panel, Session is Now Free to the Public – PRNewswire

MIAMI, July 29, 2020 /PRNewswire/ --An FDA Safety Panel discussion will be held virtually by the American Academy of Stem Cell Physicians (AASCP) Aug.1-3, 2020, with guest speakerFDA Director Dr. Peter Marks. This is a highly anticipated session which will discuss the growing safety concerns of the industry.

The AASCP has recently created guidelines thatare current safety recommendations given to physicians who are using biologics in their medical practice. A highly anticipated and sought-after Safety StandardsPanel session will be hosted VIRTUALLY by AASCP on Aug. 1-3. 2020; guest of honor isDr. Peter Marks, FDA Director of CBER. The sessions normally are closed to the public but this particular SafetyStandard Panel discussion will be open and free to the public, covering the growing safety concerns of the industry.

The Safetypanel discussion will discuss advancements in development, manufacturing and delivery of safe and effective regenerative cell therapies through policy development, consensus and advocacy. The Safety Panel discussion willbringtogether experts and stakeholders to gain consensus on and advocate for policies that will advance the science and the field, including those focused on promoting clinical research, assuring the adoption of consensus standards to promote safety and quality, building capacity and expertise within the workforce, and establishing a national outcomes database to advance the science, promote improvements in quality and safety, and inform regulatory and patient decision-making.

According to AASCP, if physicians are using biologics in their practice, whether they are using SVF, PRP, bone marrow, UCB, amniotic products, exosomes, xenograftsor peptides, there are key considerations to take into account to achieve the best safety for their patients. The AASCP also recommends communication with the Chief Scientific Officer from the laboratory they work with. AASCP advises that just talking to a sales agent is not sufficient enough when determining the quality of products for their patients. Sales agents typically do not have a medical or scientific background.

The President for the AASCP, Dr. Martin Dayton,said earlier: "The American Academy of Stem Cell Physicians is a group of physicians, scientists and researchers who collectively represent the most authoritativenon-federal group advocating for guidelines and education on stem cell therapy and regenerative medicine. AASCP members are experts within all fields of stem cell therapy fromSVF, BM, UCB, Exosomes, Peptides, Xenografts, Allografts and Amniotic Fluids and are considered the most experienced leaders for proper advocacy in the field. The AASCP is involved directly with other authorities within the field and seeks only to bring knowledge and awareness for the ever-growing regenerative medicine industry.My hope is that the SafetyPanel discussion on Aug. 1-3, 2020, is to help get rid of the bad actors that are damaging the field for everyone."

The importance of this virtual conference coincides with the ever-emerging growthof the globalregenerative medicine marketwhich is expected to reachUSD 79.8 billionby 2024, at aCAGR of 20.5%from 2018 to 2024. Factors driving the growth of the market areincreasing prevalence of degenerative and chronic diseases, technological advancements in nanotechnology, bioengineering and stem cell therapy, and increasing geriatric population across the globe.TheAASCP virtual meeting is set for Aug. 1, 2020.List of speakers is available at http://www.aascp.net.

Due to COVID-19, the meeting will take place virtually.Thisis an effective way to ensure that everyone that wishes to participate, but cannot travel, can. Students, educators and physicians will not have to miss out on all the important topics that AASCP has on the pipeline.

Virtual Workshop Lecturers will virtually demonstrate their techniques live via their professional locations. These virtualinteractive workshops will feature small participant-to-instructor ratios with a customized curriculum focusing on developing hands-on skills. Each technique will be taught by experts in the field, using didactic sessions with dynamic multimedia presentations, live demonstrations and scanning on live models, as well as phantoms.

AASCP spokesmanDr. A.J.Farshchianexplains, "We will duplicate everything we did in our past meetings such as offer CME credits, have lectures, workshops, discuss FDA safety standards, have board examinations and a virtual graduation ceremony. AASCP is offering this virtual meeting so that nobody misses out on the education."

To join the free session via Zoom, please click on the link below at 11a.m. this Saturday.

Join Zoom Meeting: https://aascp.zoom.us/j/4150937630

Meeting ID: 415 093 7630

The American Academy of Stem Cell Physicians (AASCP) is a non-profit organization created to advance research and the development of therapeutics in regenerative medicine, including diagnosis, treatment, and prevention of disease related to or occurring within the human body. Secondarily, the AASCPaims to serve as an educational resource for physicians, scientists, and the public in diseases that can be caused by physiological dysfunction that isameliorable to medical treatment.

For further information, please contact MarieBarbaat AASCP at 305-891-4686or visit us at http://www.aascp.net.

Related Images

virtual-conference-aug-1-3-2020.jpeg Virtual Conference Aug. 1-3, 2020

aascp.png AASCP

Related Links

Guest Speaker Dr. Peter Marks, FDA Director

AASCP zoom meeting

SOURCE American Academy of Stem Cell Physicians

More:
American Academy of Stem Cell Physicians is Hosting an FDA Safety Panel, Session is Now Free to the Public - PRNewswire

Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 – Market Research Posts

This latest report studies Stem Cell Therapy Market globally, particularly in North America, Europe(Germany, UK, France, Italy, Spain, Russia, Poland), China, Japan, Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam) the Middle East and Africa(Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria), India, South America(Brazil, Mexico, Colombia), with revenue, import, and export, production, consumption in these regions, from 2015 to 2019, and forecast 2020 to 2027. Global Stem Cell Therapy market 2020 research report is replete with precise analysis from radical studies, specifically on queries that approach market size, trends, share, forecast, outlook, production, and futuristic developments trends and present and future market status.

Then, the report focuses on world major leading industry players with information like company profiles, product picture and specifications, Sales Revenue, Price, gross margin, market share, and contact info. In addition, the Stem Cell Therapy industry development trends and marketing channels are analyzed.

Request For Free Sample Report:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

Analysis of Stem Cell Therapy market Key manufacturers (Sales Revenue, Price, gross margin, main products, etc.):

Celgene Corporation Osiris Therapeutics, Inc. Pharmicell Co., Ltd MEDIPOST Co., Ltd. Promethera Biosciences Fibrocell Science, Inc. Holostem Terapie Avanzate S.r.l. Cytori Therapeutics Nuvasive, Inc. RTI Surgical, Inc. Anterogen Co., Ltd. RTI Surgical, Inc

Analysis of Stem Cell Therapy Market By Product Types(Market Size & Forecast):

Adult Stem Cells Human Embryonic Induced Pluripotent Stem Cells Very Small Embryonic Like Stem Cells

Analysis of Stem Cell Therapy Market By Applications(Market Size & Forecast):

Regenerative Medicine Drug Discovery and Development

In additional, the manufacturers dominant within the global Stem Cell Therapy Market are highlighted inside the competitive landscape section of the report. The competitive state of affairs and trends current within the market have additionally been encapsulated underneath this section of the study. moreover, the mergers and acquisitions that passed off within the market in the past few years and their impact on the markets development has in addition been bestowed underneath this a part of the report.

Ask For Discount: https://www.reportspedia.com/discount_inquiry/discount/57925

Furthermore, it describes the in-depth analysis of key Stem Cell Therapy market segments and sub-segments, particularly includes evolving Stem Cell Therapy industry trends and dynamics, challenges, and competitive insights, technological breakthroughs for Stem Cell Therapy market development mapping with different opportunities. The report also analyzes the Stem Cell Therapy industry potential for every geographical region consequently.

With the list of tables and figures, the report provides key statistics on the condition of the business and could be a valuable supply of steerage and direction for firms and people curious about the market.

Any Query Or Specific Requirement? Ask to our Research expert @

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#inquiry_before_buying

TOC of Stem Cell Therapy Market Contains Following Points:

Table of Content & Table Of Figures

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#table_of_contents

See the rest here:
Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 - Market Research Posts

The surprising recovery with stem cells of 26 COVID-19 patient in Hidalgo – Explica

The treatment was applied to patients suffering from Acute Respiratory Distress Syndrome due to COVID-19. (Photo: . / Edgard Garrido)

The Governor of the State of Hidalgo, Omar Fayad Meneses, announced that through the use of mesenchymal stem cells and exosomes, 26 Hidalguenses who were severe with COVID-19 managed to recover.

This as part of a study carried out by the state government in collaboration with that of Japan, according to the newspaper El Universal. Thirty patients participated in the project, who received an innovative biotechnological therapy to treat COVID-19. They were all in serious condition, but 26 of them managed to recover as a result of the treatment.

The agreement to carry out these activities was agreed on June 13 at a meeting between the Hidalgo administration and the International Association of Cell Therapy for the New Coronavrius (IACT4C).

In presenting the results, the Governor thanked the doctor Tetsuya Fujimori and the researchers, Alex Iryiz and Sergio Alva for having been part of the project.

He assured that based on these promising results, we will seek approval in Hidalgo for this revolutionary treatment for COVID-19. In the same direction, it was reported that an authorization would be requested to make a stem cell processing center that will have a high-level technology called Prometheus.

Mexico has positioned itself in fifth place in Latin America and 13th worldwide. (Photo: . / Edgard Garrido)

Currently, the study is in its second phase, in which it is controlled and analyzes the safety and efficacy of the use of exosomes and human mesenchymal cells intravenously applied.

The Mexican media reported that the treatment was applied to patients who suffered Acute Respiratory Distress Syndrome because of COVID-19.

The president reiterated his willingness to continue collaborating with the Japanese government and that a positive aspect of the crisis is that closer ties between countries so far away are achieved.

The governor also used his Twitter account to report that to date there are 6,467 confirmed cases of COVID-19, in addition to 1,003 deaths. There are also 1,282 recovered cases and 1,282 recovered patients.

These are part of the 44,876 deaths and 402,876 confirmed cases accumulated nationwide until the 58th day of the so-called new normality. Likewise, 449,854 negative cases, 87,538 suspects and 261,457 recovered patients have been counted.

To address the pandemic, the government received on July 28, 20 ventilators for intensive care. The Ministry of Foreign Affairs (SRE) explained that the arrival of the fans was the result of cooperation between the governments of Mexico and the United States and of the conversation between the presidents. Andrs Manuel Lpez Obrador and Donald Trump on April 17, where the acquisition of equipment from that country was agreed.

The Governor thanked Dr. Tetsuya Fujimori and the researchers, Alex Iryiz and Sergio Alva for having been part of the project. (Photo: . / Edgard Garrido)

During the morning conference, the Undersecretary for Prevention and Health Promotion, Hugo Lpez-Gatell, He pointed out that in 20 states the infections of coronavirus increase day by day, however in 12 they go down.

In the mortality ranking, Mexico has positioned itself in fifth place in Latin America and 13th worldwide. About73% of deaths were associated with at least one comorbidity, mainly hypertension, diabetes and obesity.

Actually, Mexico City continues to be the entity with the highest number of active casesfollowed by Guanajuato, Nuevo Len, which rose by one place, Estado de Mxico, Veracruz, which rose by two places, Tabasco, Coahuila, which rose by one site, Jalisco, Yucatan, rose by one place, and Puebla.

MORE ABOUT THIS TOPIC:

Coronavirus in Mexico: the country exceeded 400,000 infections

20 new fans arrived in Mexico from the US

Fatigue, shortness of breath, pain: the 17 symptoms that persist after passing COVID-19

Coronavirus in Mexico: 777 people have taken refuge due to lack of government support

July 29, 2020

Read more here:
The surprising recovery with stem cells of 26 COVID-19 patient in Hidalgo - Explica